Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Now watching

Next video starts in : 7 Play

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People
Replay video
Up next

July Fourth in New York City Means Two Things: Fireworks and Hot Dog Eating Contests

Unlock your personal NFL Now stream by signing in to NFL.com

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

by TheStreet 1:02 mins

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

by TheStreet 1:02 mins

New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York.

TheStreet

Personal Finance

  1. 1:04

    Money Minute: Can I really negotiate my doctor's bills?

  2. 1:59

    Unexpected -- and brilliant -- ways these people made tons of money

  3. 1:07

    How to start investing in your 401(k)

  4. 2:23

    You can't go wrong if you major in a STEM field and other myths about college

  5. 2:17

    How much would you spend on your wedding?

  6. 1:10

    Money Minute: When is the right time to lock in your mortgage rate?